Stemline Therapeutics Inc (NASDAQ:STML)

Delayed Data
As of May 29
 +0.92 / +7.16%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Stemline Therapeutics Inc have a median target of 38.00, with a high estimate of 50.00 and a low estimate of 30.00. The median estimate represents a +175.96% increase from the last price of 13.77.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Stemline Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 13

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -0.72%
Growthannually 12.33%


Growthquarterly -48.94%
Growthannually -15.94%
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account